FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 20:35:52 02/07/2024 BST | ||
| 2.09 EUR | -2.79% |
|
| Current month | -2.84% | ||
| 1 month | +1.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 02/07/24 | 2.05 | -4.65% |
| 01/07/24 | 2.15 | +1.90% |
| 28/06/24 | 2.11 | +0.48% |
| 27/06/24 | 2.1 | +3.96% |
| 26/06/24 | 2.02 | +1.00% |
Real-time Boerse Frankfurt Warrants
Last update July 02, 2024 at 08:35 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01E1 |
| ISIN | DE000SB01E10 |
| Date issued | 09/06/2020 |
| Strike | 306.8 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.88 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.73 € |
|---|---|
| Lowest since issue | 1.48 € |
| Spread | 0.01 € |
| Spread % | 0.48% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
228.8
USD
Average target price
283.2
USD
Spread / Average Target
+23.75%
- Stock Market
- Certificates
- Certificat
